greeksoup/ stock research
Stock research / United States / OCUL / Insiders

Ocular Therapeutix, Inc. insider trading

In twelve months insiders at Ocular Therapeutix bought $461K and sold $3.3M on the open market; 25 of the 29 sales were under plans set months before.

Bought on the open market$461K1 purchase
Sold on the open market$3.3M29 sales
Sales set in advance25 of 29under Rule 10b5-1 plans
Pay taken in stockNone
New to this? How to read this page
  1. Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
  2. A purchase on the open market is the strongest sign: the insider spent their own money.
  3. A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
  4. Grants, option exercises and shares held back for tax are left out.
  5. What is a Form 4? · Form 4 codes

What kind of trades

1 purchase worth $461K against 29 sales worth $3.3M; 25 of the sales were under plans set months before.

Purchasebought with their own money
Pay in stock, own choiceowed cash, chose shares
Sale outside a planthe insider picked the day
Sale under a plandates fixed months before
Says littlecompany plans, board pay, cash units
Bought
1 open market
Sold
425 under a plan

Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.

Insider trades on the share price

last twelve months

30 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.

PurchasePay in stock, own choiceSale outside a planSale under a planSays little

The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.

Trades worth a closer look

A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.

Who traded

dollars, twelve months

9 insiders traded. The most: Dugel Pravin, sale under a plan $1.9M.

One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.

How it compares

every company on the site

Open-market sales, twelve months

Open-market purchases, twelve months

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every Form 4 line

    Purchase: bought on the open market with their own moneyTook pay in stock, own choice: owed cash, chose shares instead; a softer signSale: sold on the open market, not under a plan set in advanceSale, trading plan: under a Rule 10b5-1 plan set up months before, so the date was fixed in advanceGrey lines: plan purchases, pay in stock taken by the whole board or under a company plan, and units paid in cash; they say little about the insider's own view
    TradedInsiderRoleTypeSharesPriceValueFiling
    8 October 2026Anderman ToddChief Legal OfficerSaletrading plan set in advance · Form 144 notice 8 October 202611,984$7.29$87,363Form 4
    2 October 2026Kaiser PeterChief Development OfficerSaletrading plan set in advance · Form 144 notice 2 October 20269,990$7.05$70,430Form 4
    2 October 2026Heier Jeffrey S.Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 2 October 202610,869$7.05$76,626Form 4
    31 August 2026Notman DonaldChief Operating OfficerSaleafter a 17% rise over three months · 35% below its one-year high · Form 144 notice 31 August 20261,099$10.24$11,254Form 4
    24 August 2026Kaiser PeterChief Development OfficerSaletrading plan set in advance · Form 144 notice 24 August 20263,035$10.77$32,687Form 4
    24 August 2026Nayak SanjayChief Strategy OfficerSaletrading plan set in advance · Form 144 notice 24 August 20261,897$10.78$20,450Form 4
    24 August 2026Heier Jeffrey S.Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 24 August 20263,296$10.78$35,531Form 4
    24 August 2026Dugel PravinSee RemarksSaletrading plan set in advance · Form 144 notice 24 August 202621,649$10.77$233,160Form 4
    3 June 2026Waheed NadiaChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 June 202614,828$8.27$122,628Form 4
    26 May 2026Dugel PravinSee RemarksSaletrading plan set in advance · Form 144 notice 26 May 202621,156$8.20$173,479Form 4
    26 May 2026Kaiser PeterChief Development OfficerSaletrading plan set in advance · Form 144 notice 26 May 20262,967$8.20$24,329Form 4
    26 May 2026Heier Jeffrey S.Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 26 May 20263,018$8.20$24,748Form 4
    26 May 2026Nayak SanjayChief Strategy OfficerSaletrading plan set in advance · Form 144 notice 26 May 20261,858$8.20$15,236Form 4
    23 February 2026Dugel PravinSee RemarksSaletrading plan set in advance · Form 144 notice 23 February 202620,056$8.28$166,064Form 4
    23 February 2026Kaiser PeterChief Development OfficerSaletrading plan set in advance · Form 144 notice 23 February 20262,810$8.28$23,267Form 4
    23 February 2026Heier Jeffrey S.Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 23 February 20263,057$8.28$25,312Form 4
    23 February 2026Nayak SanjayChief Strategy OfficerSaletrading plan set in advance · Form 144 notice 23 February 20261,759$8.28$14,565Form 4
    20 February 2026Waheed NadiaChief Medical OfficerSaletrading plan set in advance · Form 144 notice 20 February 20263,510$7.74$27,167Form 4
    20 February 2026Lindstrom Richard L MdDirectorPurchaseafter a 36% fall over three months · 52% below its one-year high60,229$7.66$461,354Form 4
    12 February 2026Notman DonaldChief Operating OfficerSaleafter a 19% fall over three months · 44% below its one-year high · Form 144 notice 12 February 202611,446$9.04$103,472Form 4
    12 February 2026Nayak SanjayChief Strategy OfficerSaletrading plan set in advance · Form 144 notice 12 February 202610,348$9.04$93,546Form 4
    12 February 2026Dugel PravinSee RemarksSaletrading plan set in advance · Form 144 notice 12 February 2026124,882$9.04$1.1 millionForm 4
    12 February 2026Waheed NadiaChief Medical OfficerSaletrading plan set in advance · Form 144 notice 12 February 20267,863$9.04$71,082Form 4
    4 February 2026Notman DonaldChief Operating OfficerSaleafter a 21% fall over three months · 47% below its one-year high · Form 144 notice 4 February 20266,035$8.54$51,539Form 4
    2 February 2026Notman DonaldChief Operating OfficerSaleafter a 20% fall over three months · 43% below its one-year high · Form 144 notice 2 February 20265,455$9.14$49,859Form 4
    24 November 2025Nayak SanjayChief Strategy OfficerSaletrading plan set in advance · Form 144 notice 24 November 20251,878$12.04$22,611Form 4
    24 November 2025Dugel PravinSee RemarksSaletrading plan set in advance · Form 144 notice 24 November 202519,530$12.04$235,141Form 4
    24 November 2025Kaiser PeterChief Development OfficerSaletrading plan set in advance · Form 144 notice 24 November 20253,007$12.02$36,144Form 4
    24 November 2025Heier Jeffrey S.Chief Scientific OfficerSaletrading plan set in advance · Form 144 notice 24 November 20253,469$12.04$41,767Form 4
    5 November 2025Saroj NamrataChief Business OfficerSaletrading plan set in advance · Form 144 notice 5 November 202525,865$10.74$277,790Form 4
    A filing with several lines appears once per line.
    Read morePay taken in stock by the insider's own choice has the filing's footnote, word for word, in the note under it; for the others, hold the pointer on the type. An award filed at no price shows n/a.